Aethlon Medical Inc. of San Diego has formed a relationship with Kentucky Bioprocessing to establish processes that will support Aethlon’s Hemopurifier®, a medical device that absorbs viruses and immunosuppressive particles from the bloodstream. “The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, said Aethlon Medical CEO Jim Joyce. “Beyond a significant cost reduction of our affinity agents, the relationship offers large-yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats.”
-
Share This!
Owensboro
November 1, 2009
387 Views
You may also like
Popular Stories
Northern Kentucky University installs first female president
April 27, 2024
The Lane Report
- Northern Kentucky University installs first female president
- Stites & Harbison makes 2024 Top 10 list in Patent Lawyer Magazine
- Buffalo Trace Distillery London
- EKU Ranks for Best Occupational Therapy Programs
- U.S. Department of Education Green Ribbon Schools
- Markey’s Yang awarded $3M to study melanoma treatment target
- UK breaks ground on $781M Cancer and Advanced Ambulatory Building
- UK Trustees give final OK to acquiring St. Claire HealthCare in Morehead
- GE Appliances creates Bodewell concierge experience for consumers
- UofL scientists find measure for benefits of time in green nature
Add Comment